Connection
Anna Schreiber to Antineoplastic Agents
This is a "connection" page, showing publications Anna Schreiber has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.468 |
|
|
|
-
Schreiber AR, Verduzco-Aguirre HC, Giangiuli S, Aranda-Gutierrez A, Roy S, Soto-Perez-de-Celis E. A review of current and emerging therapies in breast cancer: implications for older adults. Expert Rev Clin Pharmacol. 2025 Oct; 18(10):1-16.
Score: 0.415
-
Quackenbush KS, Bagby S, Tai WM, Messersmith WA, Schreiber A, Greene J, Kim J, Wang G, Purkey A, Pitts TM, Nguyen A, Gao D, Blatchford P, Capasso A, Schuller AG, Eckhardt SG, Arcaroli JJ. The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance. Oncotarget. 2016 May 10; 7(19):28273-85.
Score: 0.054